Local democracy

Issue - meetings

AIREDALE AND WHARFEDALE CLINICAL COMMISSIONING GROUP

Meeting: 05/09/2019 - Keighley Area Committee (Item 25)

25 AIREDALE AND WHARFEDALE CLINICAL COMMISSIONING GROUP pdf icon PDF 59 KB

The report of the Deputy Director, Airedale, Wharfedale and Craven Clinical Commissioning Group (Document “J”) provides an annual update in relation to the outcome of the Clinical Commissioning Group Improvement and Assessment Framework and activities undertaken as part of system wide partnership working.

 

Members are invited to support further engagement through involvement of local Councillors in the activities of the community partnerships.

 

Recommended –

 

That the report be noted.

 

(Lynne Scrutton – 01274 237325)

Additional documents:

Decision:

Resolved –

 

That the report be noted and further engagement through the involvement of local Councillors in the activities of the community partnerships be supported.

 

OVERVIEW AND SCRUTINY COMMITTEE: Regeneration & Environment

ACTION: Strategic Director, Place

Minutes:

The Deputy Director, Airedale, Wharfedale and Craven Clinical Commissioning Group presented Document “J”  which provided an annual update to the committee in relation to the outcome of the Clinical Commissioning Group Improvement and Assessment Framework and activities undertaken as part of system wide partnership working.

 

The background to Document “J” reported that the Clinical Commissioning Groups (CCGs) were created following the Health and Social Care Act in 2012, and replaced Primary Care Trusts on 1 April 2013.  The CCGs are clinically-led statutory NHS bodies responsible for the planning and commissioningof health care services for their local area.

 

The report also reminded Members that the City of Bradford Metropolitan District Council was party to the Strategic Partnership Agreement (SPA) for Bradford District and Craven which set out the intent to work in partnership with health care commissioners and providers to deliver transformation and better integration of health and care services for the population of the Bradford and Craven district.

 

The Deputy Director provided a detailed PowerPoint presentation which focussed on the CCG Improvement and Assessment Framework and partnership working locally.

 

In respect to improvement and assessment Members were advised that all CCGs were assessed nationally each year.  The Airedale, Wharfedale and Craven CCG had been assessed in July 2018 as outstanding and in 2019 as good.  Definitions of the four domain areas assessed were provided and were Better Health; Better Care; Sustainability and Leadership.  Each domain was given 25% weighting.  The results of those assessments were discussed.    Members were assured that the deteriorating financial situation was the reason for any worsening assessments and not the quality of care.

 

It was explained that the CCG spent more than it received and approximately £1,500 was spent on each person registered with a GP in the area.    A pie chart depicted how an annual spend of £227.8m had been spent and showed that the largest spend was on acute hospital care.

 

Running costs were portrayed as 1% of annual spend and Members were advised that all CCGs had been instructed to make a 20% reduction to that figure by April 2020.  As a result consultation had been undertaken to close all three CCGs in the area and create one new CCG.  All member practices had voted in favour of the proposal.  It was acknowledged that bringing the CCG into financial balance would be a challenge and there would be an £8million shortfall this year.  A plan had been devised to reduce costs by £5million but it was  likely that there would be a £4.5million deficit at the start of the new financial year.

 

Members were advised that of 195 CCGs nationally the Airedale, Wharfedale and Craven CCGs had been ranked in the top cohort for the past two years.  The presentation depicted areas which had been rated good or needing improvement.   The rationale for those rankings and actions for improvement were discussed. 

 

Positive results included increased statin provision to improve cardiovascular disease; introduction of a consistent fall risk assessment providing significant improvements;  ...  view the full minutes text for item 25